Medcom Tech Stock

Medcom Tech Net Income 2025

Medcom Tech Net Income

-1.59 M EUR

Ticker

MED.MC

ISIN

ES0161857018

In 2025, Medcom Tech's profit amounted to -1.59 M EUR, a 21.92% increase from the -1.3 M EUR profit recorded in the previous year.

The Medcom Tech Net Income history

YEARNET INCOME (M EUR)
2022-1.59
2021-1.3
2020-1.84
20194.16
2018-8.5
2017-2.4
2016-2.85
2015-1.65
20140.57
20130.77
20120.35
20110.18
20101.49
20091.27
20080.63
20070.53
20060.31

Medcom Tech Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Medcom Tech, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medcom Tech from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medcom Tech’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Medcom Tech. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Medcom Tech’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Medcom Tech’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medcom Tech’s growth potential.

Medcom Tech Revenue, EBIT and net profit per share

DateMedcom Tech RevenueMedcom Tech EBITMedcom Tech Net Income
202224.92 M undefined864,700 undefined-1.59 M undefined
202122.82 M undefined992,600 undefined-1.3 M undefined
202018.56 M undefined475,500 undefined-1.84 M undefined
201922.26 M undefined719,300 undefined4.16 M undefined
201824.27 M undefined-8.07 M undefined-8.5 M undefined
201728.57 M undefined-2.37 M undefined-2.4 M undefined
201627.26 M undefined-1.72 M undefined-2.85 M undefined
201524.86 M undefined-1.33 M undefined-1.65 M undefined
201420.23 M undefined2 M undefined574,800 undefined
201318.41 M undefined2.21 M undefined770,000 undefined
201216.69 M undefined1.85 M undefined350,000 undefined
201114.48 M undefined910,000 undefined180,000 undefined
201012.3 M undefined2.21 M undefined1.49 M undefined
200910.14 M undefined2.34 M undefined1.27 M undefined
20086.8 M undefined1.45 M undefined630,000 undefined
20074.15 M undefined830,000 undefined530,000 undefined
20063.81 M undefined460,000 undefined310,000 undefined

Medcom Tech stock margins

The Medcom Tech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medcom Tech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medcom Tech.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Medcom Tech's sales revenue. A higher gross margin percentage indicates that the Medcom Tech retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Medcom Tech's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Medcom Tech's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medcom Tech's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medcom Tech. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medcom Tech's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Medcom Tech Margin History

Medcom Tech Gross marginMedcom Tech Profit marginMedcom Tech EBIT marginMedcom Tech Profit margin
202268.31 %3.47 %-6.37 %
202162.02 %4.35 %-5.71 %
202063.14 %2.56 %-9.9 %
201972.11 %3.23 %18.7 %
201855.26 %-33.26 %-35.01 %
201758.43 %-8.28 %-8.41 %
201660.95 %-6.31 %-10.47 %
201564.52 %-5.36 %-6.65 %
201460.91 %9.89 %2.84 %
201361.87 %12 %4.18 %
201264.23 %11.08 %2.1 %
201169.27 %6.28 %1.24 %
201062.11 %17.97 %12.11 %
200965.68 %23.08 %12.52 %
200871.18 %21.32 %9.26 %
200779.28 %20 %12.77 %
200663.25 %12.07 %8.14 %

Medcom Tech Aktienanalyse

What does Medcom Tech do?

Medcom Tech SA is a European company headquartered in Switzerland that specializes in the development and manufacturing of medical devices. The company was founded in 1999 and has since had an impressive history. The business model of Medcom Tech SA is based on the idea of developing medical devices that meet the needs of doctors and patients. The company works closely with medical professionals to find innovative solutions that can improve medical care and accelerate patient recovery. The goal of Medcom Tech SA is to offer high-quality, safe, and reliable products that can be used worldwide in medical practice. Medcom Tech SA offers a wide range of products divided into various sectors. One of the main sectors of the company is gastroenterology, where endoscopic devices and accessories are manufactured and distributed. These devices are a crucial foundation for the diagnosis and treatment of gastrointestinal diseases. The endoscopes enable more precise interventions and are particularly in demand for minimally invasive procedures. Another important sector of the company is cardiology. Medcom Tech SA manufactures defibrillators and implantable devices in this sector. These devices help save lives and provide patients with more security in their daily lives. In particular, implantable devices are an essential part of modern medicine and contribute to allowing patients to lead long and healthy lives. In addition to the mentioned sectors, Medcom Tech also develops and produces devices for the diagnosis and treatment of respiratory diseases, neurology, gynecology, and urology. For example, in urology, a product called ProstateCare has been developed, which is an innovative method for treating benign prostatic hyperplasia (BPH), a benign enlargement of the prostate gland. Medcom Tech SA receives support in these business sectors from a network of international distribution partners who help distribute the products worldwide. In conclusion, Medcom Tech SA has undergone an impressive development and is one of the leading companies in the medical device industry. The company has earned an excellent reputation in the medical industry and is known for its innovative solutions and high-quality products. The continuous collaboration with medical professionals and the consistent development of new technologies and products make Medcom Tech an important partner in the medical care world. Medcom Tech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Medcom Tech's Profit Margins

The profit margins of Medcom Tech represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Medcom Tech's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Medcom Tech's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Medcom Tech's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Medcom Tech’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Medcom Tech stock

How much profit has Medcom Tech made this year?

Medcom Tech has made -1.59 M EUR this year.

How has the profit developed compared to last year?

The profit has increased by 21.92% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Medcom Tech publish its earnings?

Medcom Tech publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Medcom Tech?

The profits of Medcom Tech are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Medcom Tech?

You can learn more about the earnings of Medcom Tech by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Medcom Tech pay?

Over the past 12 months, Medcom Tech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medcom Tech is expected to pay a dividend of 0 EUR.

What is the dividend yield of Medcom Tech?

The current dividend yield of Medcom Tech is .

When does Medcom Tech pay dividends?

Medcom Tech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medcom Tech?

Medcom Tech paid dividends every year for the past 0 years.

What is the dividend of Medcom Tech?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medcom Tech located?

Medcom Tech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medcom Tech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medcom Tech from 1/5/2016 amounting to 0.03 EUR, you needed to have the stock in your portfolio before the ex-date on 1/5/2016.

When did Medcom Tech pay the last dividend?

The last dividend was paid out on 1/5/2016.

What was the dividend of Medcom Tech in the year 2024?

In the year 2024, Medcom Tech distributed 0 EUR as dividends.

In which currency does Medcom Tech pay out the dividend?

The dividends of Medcom Tech are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medcom Tech

Our stock analysis for Medcom Tech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medcom Tech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.